KitoTech Medical Announces New U.S. Patent Granted on Its microMend® Wound Closure Products

KitoTech announces today that its second U.S. patent has been issued which extends IP coverage for its innovative microMend wound closure technology.

SEATTLE (PRWEB) MARCH 18, 2021

KitoTech Medical, a Seattle-based medical device company, announced today that the U.S. Patent and Trademark OJce (USPTO) has issued U.S. Patent No. 10,939,912 entitled“MICROSTRUCTURE-BASED SYSTEMS, APPARATUS, AND METHODS FOR WOUND CLOSURE.” The patent is directed atkey features of the company’s microMend® wound closure products that are based on the company’s proprietary Microstaple technology. KitoTech also has an issued patent in Europe and a newly granted patent in Japan on its microMend products.

“We are excited to have the issuance of our second U.S. patent which further strengthens the IP position for microMend products. The new patent expands our IP to protect novel aspects of the products that are essential for optimal wound closure. We believe that microMend is revolutionary in the `eld of wound closure and are committed to building a strong IP position for our fundamental technology and microMend products,” says Dr. Ronald Berenson, President and CEO of KitoTech Medical.

Original Publication：https://www.prweb.com/releases/kitotech_medical_announces_new_u_s_patent_granted_on_its_micromend_wound_closure_products/prweb17799274.htm